A plain language summary of the EORTC 1333/PEACE-3 study of enzalutamide alone vs enzalutamide plus radium-223 in patients with metastatic castrationresistant prostate cancer (mCRPC) and bone metastases.

ABSTRACT:

SUBMITTER: Tombal B 

PROVIDER: S-EPMC12758334 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature